Trexquant Investment LP Lexicon Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$1.2 - $6.66 $17,475 - $96,989	-14,563 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$5.35 - $7.11 $77,912 - $103,542	14,563 New	14,563 $92,000
Q1 2019 May 13, 2019	SELL	$4.36 - $7.94 $44,110 - $80,328	-10,117 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$6.15 - $10.51 $45,288 - $77,395	-7,364 Reduced 42.13%	10,117 $67,000
Q3 2018 Nov 09, 2018	SELL	$10.32 - $13.06 $22,652 - $28,666	-2,195 Reduced 11.16%	17,481 $187,000
Q2 2018 Aug 07, 2018	SELL	$7.8 - $13.69 $7,854 - $13,785	-1,007 Reduced 4.87%	19,676 $236,000
Q1 2018 May 03, 2018	BUY	$7.86 - $11.39 $162,568 - $235,579	20,683 New	20,683 $177,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.